I
Inhibikase Therapeutics D
D
IKT
2.36000
USD
-0.06
(-2.28%)
مغلق
حجم التداول
6,155
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
17,615,205
المقالات
العنوان: Inhibikase Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.